688520 神州细胞
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)-540.910-48.82794.728224.112-475.870
总资产报酬率 ROA (%)-7.1163.730-14.521-25.261-57.092
投入资产回报率 ROIC (%)-8.4174.625-18.787-35.586-85.652

边际利润分析
销售毛利率 (%)94.09095.91397.11096.68994.761
营业利润率 (%)-12.66022.6210.337-34.958-637.576
息税前利润/营业总收入 (%)-13.9348.508-15.291-42.225-624.971
净利润/营业总收入 (%)-19.1544.471-21.026-50.827-646.514

收益指标分析
经营活动净收益/利润总额(%)71.443442.2805.63675.009102.089
价值变动净收益/利润总额(%)-5.8961.126-0.624-1.174-1.125
营业外收支净额/利润总额(%)33.902-405.929101.60431.2231.383

偿债能力分析
流动比率 (X)0.6100.7260.5231.1160.885
速动比率 (X)0.5010.5970.4230.9760.750
资产负债率 (%)101.45695.891122.285108.852116.822
带息债务/全部投入资本 (%)97.41885.421114.83269.03598.459
股东权益/带息债务 (%)-1.5156.131-24.270-16.601-27.002
股东权益/负债合计 (%)-1.2634.474-18.032-7.946-14.120
利息保障倍数 (X)-2.6692.108-2.667-4.908-29.010

营运能力分析
应收账款周转天数 (天)137.71873.10860.37460.424218.568
存货周转天数 (天)1,021.175810.0351,302.1971,496.6883,297.920